Form Bio Co. Ltd. Cash Flow-to-Debt Ratio
Form Bio Co. Ltd. cash flow-to-debt ratio. Form Bio Co. Ltd. (377220) has a Cash Flow-to-Debt Ratio of -0.04x as of June 2026, meaning its operating cash flow of ₩-1.40 Billion could theoretically repay 0% of its total liabilities (₩39.64 Billion) in one year. Check 377220 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Form Bio Co. Ltd. (2019–2025)
Cash flow-to-debt ratio of Form Bio Co. Ltd. from 2019 to 2025. Historical debt coverage capacity for Form Bio Co. Ltd. across 7 annual periods. Check cash flow reinvestment rate of Form Bio Co. Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Form Bio Co. Ltd. Cash Flow-to-Debt Ratio by Year (2019–2025)
Form Bio Co. Ltd. cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Form Bio Co. Ltd.. For the full cash flow conversion analysis, see Form Bio Co. Ltd. cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | ₩-10.07 Billion | ₩39.11 Billion | ▲ +43.8% |
| 2024 | -0.46x | ₩-14.70 Billion | ₩32.07 Billion | ▲ +51.2% |
| 2023 | -0.94x | ₩-20.85 Billion | ₩22.19 Billion | ▼ -172.4% |
| 2022 | -0.34x | ₩-2.02 Billion | ₩5.87 Billion | ▼ -251.8% |
| 2021 | -0.10x | ₩-1.17 Billion | ₩11.99 Billion | ▼ -113.4% |
| 2020 | 0.73x | ₩15.61 Billion | ₩21.35 Billion | ▲ +343.5% |
| 2019 | 0.16x | ₩5.68 Billion | ₩34.45 Billion | — |